Labcorp Shares Outstanding 2010-2025 | LH

Labcorp shares outstanding history from 2010 to 2025. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Labcorp shares outstanding for the quarter ending March 31, 2025 were 0.084B, a 0.47% decline year-over-year.
  • Labcorp 2024 shares outstanding were 0.084B, a 3.65% decline from 2023.
  • Labcorp 2023 shares outstanding were 0.088B, a 4.37% decline from 2022.
  • Labcorp 2022 shares outstanding were 0.092B, a 6.05% decline from 2021.
Labcorp Annual Shares Outstanding
(Millions of Shares)
2024 84
2023 88
2022 92
2021 98
2020 98
2019 99
2018 103
2017 104
2016 104
2015 101
2014 86
2013 92
2012 97
2011 102
2010 105
2009 109
Labcorp Quarterly Shares Outstanding
(Millions of Shares)
2025-03-31 84
2024-12-31 84
2024-09-30 84
2024-06-30 84
2024-03-31 85
2023-12-31 88
2023-09-30 87
2023-06-30 89
2023-03-31 89
2022-12-31 92
2022-09-30 91
2022-06-30 93
2022-03-31 94
2021-12-31 98
2021-09-30 97
2021-06-30 98
2021-03-31 99
2020-12-31 98
2020-09-30 98
2020-06-30 98
2020-03-31 97
2019-12-31 99
2019-09-30 98
2019-06-30 99
2019-03-31 100
2018-12-31 103
2018-09-30 103
2018-06-30 103
2018-03-31 103
2017-12-31 104
2017-09-30 104
2017-06-30 104
2017-03-31 104
2016-12-31 104
2016-09-30 105
2016-06-30 104
2016-03-31 104
2015-12-31 101
2015-09-30 103
2015-06-30 103
2015-03-31 94
2014-12-31 86
2014-09-30 87
2014-06-30 86
2014-03-31 87
2013-12-31 92
2013-09-30 91
2013-06-30 94
2013-03-31 95
2012-12-31 97
2012-09-30 97
2012-06-30 98
2012-03-31 99
2011-12-31 102
2011-09-30 102
2011-06-30 103
2011-03-31 103
2010-12-31 105
2010-09-30 104
2010-06-30 105
2010-03-31 107
2009-12-31 109
2009-09-30 109
2009-06-30 110
2009-03-31 109
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $20.839B $13.009B
Laboratory Corporation of America Holdings or LabCorp is a leading healthcare diagnostics company, providing comprehensive clinical laboratory services and end-to-end drug development support. The provide vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $90.020B 21.74
Becton Dickinson (BDX) United States $49.466B 12.25
Cardinal Health (CAH) United States $36.861B 19.31
Straumann Holding AG (SAUHY) Switzerland $20.586B 0.00
West Pharmaceutical Services (WST) United States $15.149B 31.75
Cooper (COO) United States $13.655B 17.60
Align Technology (ALGN) United States $13.115B 26.03
Henry Schein (HSIC) United States $8.519B 14.61
Merit Medical Systems (MMSI) United States $5.616B 27.15
DENTSPLY SIRONA (XRAY) United States $3.185B 9.51
CONMED (CNMD) United States $1.756B 13.14
STAAR Surgical (STAA) United States $0.882B 0.00
Lifevantage (LFVN) United States $0.164B 16.95
Pro-Dex (PDEX) United States $0.131B 14.30